Biopharmaceutical Fermentation Systems Market Size, Share, And Trends By Product (Upstream, And Downstream), By Application ( Monoclonal Antibodies, Antibiotics, Probiotics, And Others), By End User ( Academic Research Institutions, And Food Industry), And Geography - Forecasts From 2019 To 2024
- Published : Mar 2020
- Report Code : KSI061612719
- Pages : 118
Offered with this report
Market Data and Estimates in Excel
2 Months of Post Sale Analyst Support
Requirement Specific Customization
Biopharmaceuticals are mostly therapeutic recombinant proteins obtained by biotechnological processes. There has been increased usage of fermentation-derived biopharmaceuticals due to their natural structure, low cost, and better output. Research and development in the field of biopharmaceutical fermentation and launch of new products are expected to drive the growth of the market. Rise of geriatric population and increaing prevalence of chronic diseases is expected to propel the demand for biopharmaceuticals during the forecast period. In addition, increased expenditure on healthcare in different countries is further anticipated to increase the demand for drugs thus leading to market growth opportunites over the next five years. But the availability of substitutes is expected to restrain the growth of the market. The downstream process products segment is expected to have a significant market share due to stringent regulations and the trend of continuous manufacturing & single-use technology. By application, the recombinant protein segment is likely to have a significant market share. Advancement in recombinant technologies, high production capacities and a large number of raw material suppliers is expected to lead to the growth of this market segment. The Asia Pacific segment is expected to offer significant opportunities due to changing economic profiles, rapid urbanization, rise in health care spending and investment, and an increase in the incidence of chronic lifestyle diseases
DRIVERS
Technological advancement
Increased healthcare expenditure
Increase in prevalence of chronic diseases
RESTRAINT
Availability of substitutes
INDUSTRY UPDATE
InFebruary 2019, GE announced its [plan to sell its biopharma unit to Danaher for approximately $21.4 billion
In May, 2017 Dr.Reddy’s announced its plan to expand its biosimilar manufacturing capacity in Hyderabad by 4000 L using GE healthcare’s FlexFactory platform based on single use technology.
SEGMENTATION
The Biopharmaceutical Fermentation System Market has been analyzed through the following segments:
By Product
Upstream products
Downstream products
By application
Recombinant proteins
Monoclonal antibodies
Antibiotics
Probiotics
Others
By end user
Biopharmaceutical companies
Contract manufacturing organizations
Academic research institutions
Food industry
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Others
1. INTRODUCTION
1.1. MARKET OVERVIEW
1.2. MARKET DEFINITION
1.3. SCOPE OF THE STUDY
1.4. CURRENCY
1.5. ASSUMPTIONS
1.6. BASE, AND FORECAST YEARS TIMELINE
2. RESEARCH METHODOLOGY
2.1. RESEARCH DESIGN
2.2. SECONDARY SOURCES
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. MARKET SEGMENTATION
4.2. MARKET DRIVERS
4.3. MARKET RESTRAINTS
4.4. MARKET OPPORTUNITIES
4.5. PORTER’S FIVE FORCE ANALYSIS
4.5.1. BARGAINING POWER OF SUPPLIERS
4.5.2. BARGAINING POWER OF BUYERS
4.5.3. THREAT OF NEW ENTRANTS
4.5.4. THREAT OF SUBSTITUTES
4.5.5. COMPETITIVE RIVALRY IN THE INDUSTRY
4.6. LIFE CYCLE ANALYSIS - REGIONAL SNAPSHOT
4.7. MARKET ATTRACTIVENESS
5. BIOPHARMACEUTICALS FERMENTATION SYSTEMS MARKET BY PRODUCT
5.1. UPSTREAM PRODUCTS
5.2. DOWNSTREAM PRODUCTS
6. BIOPHARMACEUTICALS FERMENTATION SYSTEMS MARKET BY APPLICATION
6.1. RECOMBINANT PROTEINS
6.2. MONOCLONAL ANTIBODIES
6.3. ANTIBIOTICS
6.4. PROBIOTICS
7. BIOPHARMACEUTICALS FERMENTATION SYSTEMS MARKET BY END USER
7.1. BIOPHARMACEUTICALS COMPANIES
7.2. CONTRACT MANUFACTURING COMPANIES
7.3. ACADEMIC RESEARCH INSTITUTIONS
7.4. FOOD INDUSTRY
8. BIOPHARMACEUTICALS FERMENTATION SYSTEMS MARKET BY GEOGRAPHY
8.1. NORTH AMERICA
8.1.1. USA
8.1.2. CANADA
8.1.3. MEXICO
8.2. SOUTH AMERICA
8.2.1. BRAZIL
8.2.2. ARGENTINA
8.2.3. OTHERS
8.3. EUROPE
8.3.1. GERMANY
8.3.2. FRANCE
8.3.3. UNITED KINGDOM
8.3.4. SPAIN
8.3.5. OTHERS
8.4. MIDDLE EAST AND AFRICA
8.4.1. SAUDI ARABIA
8.4.2. ISRAEL
8.4.3. OTHERS
8.5. ASIA PACIFIC
8.5.1. CHINA
8.5.2. JAPAN
8.5.3. SOUTH KOREA
8.5.4. INDIA
8.5.5. OTHERS
9. COMPETITIVE INTELLIGENCE
9.1. COMPANY BENCHMARKING AND ANALYSIS
9.2. RECENT INVESTMENT AND DEALS
9.3. STRATEGIES OF KEY PLAYERS
10. COMPANY PROFILES
10.1. GE HEALTHCARE
10.2. MERCK KGAA
10.3. THERMO FISHER SCIENTIFIC
10.4. SARTORIUS STEDIM BIOTECH
10.5. DANAHER CORPORATION
10.6. EPPENDORF AG
10.7. F.HOFFMAN-LA ROCHE LTD
10.8. NOVA BIOMEDICAL
10.9. LONZA
10.10. BECTON DICKINSON AND COMPANY
LIST OF FIGURES
LIST OF TABLES
GE Healthcare
Merck KGaA
Thermo Fisher Scientific
Sartorius Stedim Biotech
Danaher Corporation
Eppendorf AG
F. Hoffmann-La Roche Ltd.
Nova Biomedicals
Lonza
BectonDickinson and Company
Related Reports
| Report Name | Published Month | Get Sample PDF |
|---|---|---|
| Algaecides Market Size, Share & Trends: Industry Report, 2023 - 2028 | Jan 2023 | |
| Bioherbicides Market Size, Share & Trend: Industry Report, 2022-2027 | Mar 2022 | |
| Probiotics Dietary Supplement Market Size: Report, 2024–2029 | Mar 2024 | |
| Nematicides Market Size & Share: Industry Report, 2022–2027 | Aug 2022 | |
| Agrochemicals Market Size, Share & Growth: Report, 2021–2026 | Nov 2021 |